Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Pleural Mesothelioma”

147 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 147 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Testing effectiveness (Phase 2)Study completedNCT02414945
What this trial is testing

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Who this might be right for
Pleural Mesothelioma
University Health Network, Toronto 9
Testing effectiveness (Phase 2)Study completedNCT01243632
What this trial is testing

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

Who this might be right for
Malignant Pleural Mesothelioma
Institute of Oncology Ljubljana 78
Testing effectiveness (Phase 2)Study completedNCT00165516
What this trial is testing

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 85
Testing effectiveness (Phase 2)Study completedNCT00634205
What this trial is testing

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Lung Cancer Working Party 45
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)UnknownNCT02588131
What this trial is testing

Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
Italian Network for Tumor Biotherapy Foundation 40
Testing effectiveness (Phase 2)WithdrawnNCT01353482
What this trial is testing

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University College, London
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Testing effectiveness (Phase 2)Study completedNCT00334594
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 153
Testing effectiveness (Phase 2)Ended earlyNCT01861301
What this trial is testing

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Epithelioid MesotheliomaRecurrent Malignant MesotheliomaSarcomatoid Mesothelioma+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT01279967
What this trial is testing

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Barts & The London NHS Trust 70
Testing effectiveness (Phase 2)Looking for participantsNCT06875076
What this trial is testing

Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma

Who this might be right for
Pretreated Pleural Mesothelioma
The First Hospital of Jilin University 25
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Testing effectiveness (Phase 2)Study completedNCT00243074
What this trial is testing

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT02347917
What this trial is testing

BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Sumitomo Pharma Co., Ltd. 28
Load More Results